Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 14 studies | 27% ± 9% | |
| pericyte | 11 studies | 27% ± 7% | |
| smooth muscle cell | 7 studies | 22% ± 9% | |
| connective tissue cell | 5 studies | 27% ± 8% | |
| pancreatic A cell | 4 studies | 50% ± 9% | |
| hepatocyte | 3 studies | 45% ± 16% |
Insufficient scRNA-seq data for expression of F10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 5259.91 | 226 / 226 | 99% | 226.29 | 401 / 406 |
| prostate | 98% | 859.27 | 241 / 245 | 88% | 9.01 | 440 / 502 |
| adrenal gland | 92% | 531.86 | 238 / 258 | 81% | 61.69 | 187 / 230 |
| stomach | 80% | 454.28 | 286 / 359 | 59% | 9.98 | 168 / 286 |
| lung | 100% | 964.13 | 576 / 578 | 32% | 2.84 | 364 / 1155 |
| kidney | 69% | 214.78 | 61 / 89 | 60% | 15.21 | 542 / 901 |
| ovary | 100% | 1757.97 | 180 / 180 | 29% | 2.77 | 123 / 430 |
| intestine | 77% | 365.77 | 741 / 966 | 52% | 8.08 | 273 / 527 |
| breast | 97% | 811.68 | 447 / 459 | 30% | 1.75 | 334 / 1118 |
| bladder | 100% | 810.62 | 21 / 21 | 25% | 3.05 | 127 / 504 |
| pancreas | 41% | 122.88 | 136 / 328 | 83% | 24.03 | 148 / 178 |
| uterus | 100% | 1267.67 | 170 / 170 | 19% | 3.50 | 89 / 459 |
| thymus | 94% | 593.22 | 617 / 653 | 15% | 0.84 | 91 / 605 |
| skin | 96% | 981.66 | 1736 / 1809 | 13% | 0.98 | 63 / 472 |
| esophagus | 84% | 494.23 | 1217 / 1445 | 22% | 2.13 | 40 / 183 |
| adipose | 99% | 1219.38 | 1195 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 899.89 | 1318 / 1335 | 0% | 0 | 0 / 0 |
| heart | 92% | 1120.57 | 795 / 861 | 0% | 0 | 0 / 0 |
| spleen | 58% | 176.30 | 140 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 33% | 5.13 | 26 / 80 |
| muscle | 28% | 73.30 | 225 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 1.12 | 8 / 29 |
| brain | 4% | 9.09 | 116 / 2642 | 4% | 0.24 | 27 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.17 | 2 / 45 |
| peripheral blood | 1% | 2.57 | 5 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_0007596 | Biological process | blood coagulation |
| GO_0006508 | Biological process | proteolysis |
| GO_0032008 | Biological process | positive regulation of TOR signaling |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004252 | Molecular function | serine-type endopeptidase activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005543 | Molecular function | phospholipid binding |
| Gene name | F10 |
| Protein name | Coagulation factor X (EC 3.4.21.6) (Stuart factor) Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain] Coagulation factor X |
| Synonyms | hCG_27879 |
| Description | FUNCTION: Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting. FUNCTION: Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting. . FUNCTION: Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting. . FUNCTION: Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting. . FUNCTION: Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting. . |
| Accessions | B7ZBK1 ENST00000375559.8 P00742 ENST00000375551.7 ENST00000410083.6 O15095 ENST00000409306.5 Q5JVE7 Q5JVE8 F8WBM7 |
